Search Constraints
« Previous |
1 - 20 of 24
|
Next »
Search Results
Select an image to start the slideshow
Molecular Basis of NMDA Receptor Allosteric Regulation by New
Subunit-selective Modulators
1 of 20
Identifying Novel Therapeutic Strategies for Enhancing Social
Cognition Using Functional Animal Models
2 of 20
Stereospecificity of the prosocial and neurotoxic effects of
3,4-methylenedioxymethamphetamine (MDMA) in mice
3 of 20
Comprehensive Proteome and Transcriptome Studies Reveal RNA
Processing Dysfunction in Alzheimer's disease
4 of 20
The Effects of Early Life Stress on Decision Making Under Risk,
Response Inhibition, and Error Processing as Risk Factors for
Cocaine Addiction
5 of 20
The long-term effects of prenatal stress and/or antidepressant
exposure in rats
6 of 20
Discovery and Development of Selective M1 Agonists
that Protect Against Alzheimer's Pathology and Bias Hippocampal
Circuitry Dynamics in Rodents
7 of 20
Activation and regulation of the brain-expressed adhesion G
protein-coupled receptors ADGRB1/BAI1 and ADGRB2/BAI2: Implications
for human disease
8 of 20
Reduced vesicular storage of catecholamines in the pathogenesis of
Parkinson's Disease
9 of 20
Microglial motility under pro-inflammatory conditions in situ:
Relevance to neurodegeneration
10 of 20
Examination of Phasic and Sustained Fear Responses Using a Novel
Sustained Fear Conditioning Paradigm
11 of 20
Neurochemical, neuroprotective, and behavioral effects of enhanced
vesicular storage of dopamine
12 of 20
The Role of RGS14 in Learning, Memory, and Synaptic Plasticity
13 of 20
Trafficking and Signaling of Parkin-AssociatedEndothelin-Like Receptor GPR37
14 of 20
The Transitional States of Drug Addiction in Rhesus Monkeys
15 of 20
Cortical mechanisms and developmental contributions to habit formation
16 of 20
Therapeutic effect of Berberine on Huntington's Disease Transgenic Mouse Model
17 of 20
Impaired vesicular storage of norepinephrine and serotonin in Parkinson's disease-related pathogenesis
18 of 20
In Vivo Investigation of Escitalopram's Allosteric Site on the Serotonin Transporter
19 of 20
Factors that modulate Ca2+-dependent regulation ofCav2.1 (P/Q-type) Ca2+ channels
20 of 20